Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Brustmann

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Case Reports in Pathology|March 4, 2017
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder Metastatic to the Duodenum: A Case Report-Diagnostic Relevance of GATA3 ImmunohistochemistryHermann Brustmann
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2005
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasiaHermann Brustmann
Gynecologic Oncology|July 12, 2005
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic studyHermann Brustmann
Pathology, Research and Practice|January 30, 2007
Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissuesHermann Brustmann
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 27, 2008
Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcomeHermann Brustmann
Gynecologic Oncology|September 24, 2004
Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosisHermann Brustmann
Gynecologic Oncology|January 31, 2004
Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical studyHermann Brustmann
Pathology Research International|April 9, 2015
p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12Hermann Brustmann
Gynecologic Oncology|December 26, 2001
Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stageHermann Brustmann, Susanna Naudé
Annals of Diagnostic Pathology|September 16, 2009
Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervixHermann Brustmann, Martina Hager
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Case Reports in Pathology|March 4, 2017
Plasmacytoid Urothelial Carcinoma of the Urinary Bladder Metastatic to the Duodenum: A Case Report-Diagnostic Relevance of GATA3 ImmunohistochemistryHermann Brustmann
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 23, 2005
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT), topoisomerase IIalpha expression, and apoptosis in endometrial adenocarcinoma and atypical hyperplasiaHermann Brustmann
Gynecologic Oncology|July 12, 2005
Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic studyHermann Brustmann
Pathology, Research and Practice|January 30, 2007
Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissuesHermann Brustmann
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 27, 2008
Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcomeHermann Brustmann
Gynecologic Oncology|September 24, 2004
Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosisHermann Brustmann
Gynecologic Oncology|January 31, 2004
Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical studyHermann Brustmann
Pathology Research International|April 9, 2015
p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12Hermann Brustmann
Gynecologic Oncology|December 26, 2001
Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stageHermann Brustmann, Susanna Naudé
Annals of Diagnostic Pathology|September 16, 2009
Nucleoporin 88 expression in normal and neoplastic squamous epithelia of the uterine cervixHermann Brustmann, Martina Hager
Pageof 4